Konstantinos Giannakakis
- Co-authors
- Tullio FaraggianaAndrea Onetti MudaAmandine ViauCaroline TreinsMartine BurtinMario PendeTobias B. HuberStefan Zschiedrich
- Topics
- Renal Diseases and Glomerulopathies (13 papers)Chronic Kidney Disease and Diabetes (5 papers)Systemic Lupus Erythematosus Research (5 papers)
- Cited by
- NephrologyRheumatologyImmunology
- Partner nations
- ItalyGreeceUnited States
In The Last Decade
Konstantinos Giannakakis
27 papers receiving 454 citations
Peers
Comparison fields: 5 of 75
- Nephrology 230
- Molecular Biology 155
- Immunology 99
- Rheumatology 75
- Pathology and Forensic Medicine 51
Countries citing papers authored by Konstantinos Giannakakis
This map shows the geographic impact of Konstantinos Giannakakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantinos Giannakakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantinos Giannakakis more than expected).
Fields of papers citing papers by Konstantinos Giannakakis
This network shows the impact of papers produced by Konstantinos Giannakakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantinos Giannakakis. The network helps show where Konstantinos Giannakakis may publish in the future.
Co-authorship network of co-authors of Konstantinos Giannakakis
This figure shows the co-authorship network connecting the top 25 collaborators of Konstantinos Giannakakis. A scholar is included among the top collaborators of Konstantinos Giannakakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantinos Giannakakis. Konstantinos Giannakakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 17 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | 34 | |
| 10 | 32 | |
| 11 | 10 | |
| 12 | 171 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 16 | |
| 16 | 32 | |
| 17 | Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis. | 9 |
| 18 | 27 | |
| 19 | 36 | |
| 20 | 4 |
About Konstantinos Giannakakis
Konstantinos Giannakakis is a scholar working on Nephrology, Rheumatology and Hematology, having authored 28 papers that have together received 459 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (5 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Nephrology (230 citations), Rheumatology (75 citations) and Immunology (99 citations). Konstantinos Giannakakis has collaborated with scholars based in Italy, Greece and United States. Frequent co-authors include Tullio Faraggiana, Andrea Onetti Muda, Amandine Viau, Caroline Treins, Martine Burtin, Mario Pende, Tobias B. Huber, Stefan Zschiedrich, Guillaume Canaud and Marco Pontoglio. Their work appears in journals such as Nature Medicine, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.